Powertoothbrushing for Treating Gingivitis
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Wisconsin
-
Milwaukee、Wisconsin、アメリカ、53233
- Marquette University School of Dentistry
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
A subject who meets all the following criteria will be eligible to enroll in this study.
- Age range 18 - 65 years
- Routine manual toothbrush user
- A Subject who agrees to use the assigned toothbrush as the only cleaning device for the study duration, refraining from daily interdental cleaning and/ or antiseptic mouthrinsing.
- Mild to moderate gingivitis as measured by A. Modified Gingival Index (MGI) average score of at least 1.2, and / or B. Bleeding on Probing (BOP) of at least 20% of all sites but not more than 50% of sites.
- Probing Pocket Depth (PPD) of 4 mm or lower
- At least 20 natural teeth - scoreable (crowns or bridgework are non-scoreable).
Exclusion Criteria:
Any subject meeting one of the following criteria will not be included in the study.
- Daily user of interdental cleaning devices, such as floss, floss picks, toothpicks, interdental brush, water flossing device
- Regular user of antimicrobial mouthrinses within one week of entry into study
- Professional prophylaxis within one month of entry into the study
- Use of antibiotics within one month prior to the baseline exam
- Signs of moderate to severe periodontitis or caries, categorized as PPD of 5 mm of higher and attachment loss of 3 mm or higher
- Subjects with orthodontic bands and/or dental appliances.
- Participated in an oral care related study in the last 90 days prior to this study
- Pregnant or lactating women
- Patients with a history of significant cardiovascular disease, diabetes, cancer, AIDS, or other organ impairment that would preclude their participation in the study
- Acute/concurrent illness such as hepatitis, herpes simplex infections, influenza, etc.
- History of rheumatic fever, cardiovascular valvular disease, artificial joint replacement or kidney or liver disorders
- Chronic use of steroids; limited use of NSAID's (≤ 325 mg/day)
- Current Smoker (within the last 3 months)
- Other medical or dental conditions that would affect the study
- Inability to commit to all necessary study visits from baseline to 12 weeks
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Powered toothbrush intervention
Subjects will be provided an oscillating rotating powered toothbrush as the experimental intervention, and given written instructions on its proper use.
Efficacy of overnight plaque reduction will be assessed at baseline and both gingivitis and plaque reduction will be assessed as change from baseline at 2, 4 and 12 weeks.
Subjects will be given a standard fluoride toothpaste and asked to refrain from daily interproximal plaque control for the duration of the study.
|
a battery powered oscillating rotating toothbrush will be used for twice daily regular home dental hygiene
他の名前:
|
|
介入なし:Manual toothbrush
Subjects will be provided a manual toothbrush as the control group and given written instructions on its proper use.
Efficacy of overnight plaque reduction will be assessed at baseline and both gingivitis and plaque reduction will be assessed as change from baseline at 2, 4 and 12 weeks.
Subjects will be given a standard fluoride toothpaste and asked to refrain from daily interproximal plaque control for the duration of the study.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Gingivitis
時間枠:12 weeks post-baseline
|
Baseline and 12 weeks post-baseline measures. Proportion of bleeding sites per patient was used as Full mouth BOP Score. The score for each site was either 1 for bleeding and 0 for no bleeding. Following is the full description of each outcome measure reported in the protocol. The Modified Gingival Index3 (MGI) will be measured on six sites - mesio-buccal, buccal, disto-buccal, mesio-lingual, lingual and disto-lingual - of all teeth using a 0-4 scale. Lower score no inflamation and higher severe inflammation. Dental plaque will be evaluated using the Lobene modification4 of the Turesky modification of the Quigley-Hein Plaque Index (PI)5. The score 0 to 5. Lower score means no plaque and higher score increasing plaque.Full-mouth Probing Pocket Depth (PPD) will be measured on the six locations of each tooth (mesial-buccal, buccal, distal-buccal, mesial-lingual, lingual, distal-lingual) using a periodontal probe. |
12 weeks post-baseline
|
協力者と研究者
スポンサー
協力者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。